Health professionals reminded of Zostavax safety risk

The TGA has received a report of a death occurring in a person with pre-existing compromised immune function after receiving Zostavax The vaccine for the prevention of herpes zoster has been included on the National Immunisation Program since 1 November 2016 for patients 70 years of age. A five-year catch-up program for people aged 71-79 years is also underway.